- J&J expands global access to TB drug as popular novelist joins advocacy campaign STAT
- Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries Forbes
- After Pushback, J&J Allows Generics of Its TB Drug Medpage Today
- Agreement On TB Drug Is ‘Stop Gap’ That Excludes High-Burden Countries In Eastern Europe And Central Asia Health Policy Watch
- J&J allows generic production for TB drug following public dissent Pharmaceutical Technology
- View Full Coverage on Google News
Read original article here